Suppr超能文献

基于螺环二酮哌嗪的 CCR5 拮抗剂:改善其药代动力学特征。

Spirodiketopiperazine-based CCR5 antagonists: Improvement of their pharmacokinetic profiles.

机构信息

Minase Research Institute, Ono Pharmaceutical Co., Ltd, Shimamoto, Mishima, Osaka 618-8585, Japan.

出版信息

Bioorg Med Chem Lett. 2010 Jan 15;20(2):763-6. doi: 10.1016/j.bmcl.2009.11.018. Epub 2009 Nov 12.

Abstract

Spirodiketopiperazine-based CCR5 antagonists, showing improved pharmacokinetic profiles without reduction in antagonist activity, were designed and synthesized. We also demonstrate the anti-HIV activity of a representative compound 12, as measured in a p24 assay.

摘要

基于螺环二酮哌嗪的 CCR5 拮抗剂,在不降低拮抗活性的情况下显示出改善的药代动力学特征,被设计和合成。我们还展示了代表性化合物 12 的抗 HIV 活性,该活性通过 p24 测定来衡量。

相似文献

1
Spirodiketopiperazine-based CCR5 antagonists: Improvement of their pharmacokinetic profiles.
Bioorg Med Chem Lett. 2010 Jan 15;20(2):763-6. doi: 10.1016/j.bmcl.2009.11.018. Epub 2009 Nov 12.
2
Spirodiketopiperazine-based CCR5 antagonist: discovery of an antiretroviral drug candidate.
Bioorg Med Chem Lett. 2011 Feb 15;21(4):1141-5. doi: 10.1016/j.bmcl.2010.12.109. Epub 2010 Dec 28.
3
Discovery of orally available spirodiketopiperazine-based CCR5 antagonists.
Bioorg Med Chem. 2010 Jul 15;18(14):5208-23. doi: 10.1016/j.bmc.2010.05.057. Epub 2010 May 25.
5
Novel hexahydropyrrolo[3,4-c]pyrrole CCR5 antagonists.
Bioorg Med Chem Lett. 2010 May 15;20(10):3116-9. doi: 10.1016/j.bmcl.2010.03.095. Epub 2010 Mar 30.

引用本文的文献

2
Spirodiketopiperazine-based CCR5 antagonist: discovery of an antiretroviral drug candidate.
Bioorg Med Chem Lett. 2011 Feb 15;21(4):1141-5. doi: 10.1016/j.bmcl.2010.12.109. Epub 2010 Dec 28.
3
Discovery of orally available spirodiketopiperazine-based CCR5 antagonists.
Bioorg Med Chem. 2010 Jul 15;18(14):5208-23. doi: 10.1016/j.bmc.2010.05.057. Epub 2010 May 25.

本文引用的文献

1
Developing clinical role of a CCR5 co-receptor antagonist in HIV-1 infection.
Expert Opin Pharmacother. 2008 Dec;9(18):3231-42. doi: 10.1517/14656560802576324.
2
Spirodiketopiperazine-based CCR5 antagonists: Lead optimization from biologically active metabolite.
Bioorg Med Chem Lett. 2007 Feb 1;17(3):727-31. doi: 10.1016/j.bmcl.2006.10.084. Epub 2006 Nov 1.
4
The HIV entry inhibitors revisited.
Curr Med Chem. 2006;13(8):911-34. doi: 10.2174/092986706776361030.
5
A comprehensive listing of bioactivation pathways of organic functional groups.
Curr Drug Metab. 2005 Jun;6(3):161-225. doi: 10.2174/1389200054021799.
7
New therapeutics that modulate chemokine networks.
Nat Rev Drug Discov. 2002 May;1(5):347-58. doi: 10.1038/nrd795.
9
Chemokines and disease.
Nat Immunol. 2001 Feb;2(2):108-15. doi: 10.1038/84209.
10
Multicomponent Reactions with Isocyanides.
Angew Chem Int Ed Engl. 2000 Sep 15;39(18):3168-3210. doi: 10.1002/1521-3773(20000915)39:18<3168::aid-anie3168>3.0.co;2-u.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验